Chartwell Pennsylvania, Lp
Home Infusion Therapy Pharmacy
1518 9th Avenue, Altoona
Pennsylvania, 16602-2417
814-941-0106 412-920-2883
Chartwell Pennsylvania, Lp is a Home Infusion Therapy Pharmacy in Altoona, Pennsylvania. This organization is also known as sub part of Upmc. It is located at 1518 9th Avenue, Altoona and it's customer support contact number is 814-941-0106. The authorized person of Chartwell Pennsylvania, Lp is Kathleen Patrick who is President of the pharmacy and his contact number is 412-733-1910. Chartwell Pennsylvania, Lp accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Chartwell Pennsylvania, Lp is pharmacy-based, decentralized patient care organization with expertise in USP 797-compliant sterile drug compounding that provides care to patients with acute or chronic conditions generally pertaining to parenteral administration of drugs, biologics and nutritional formulae administered through catheters and/or needles in home and alternate sites. Extensive professional pharmacy services, care coordination, infusion nursing services, supplies and equipment are provided to optimize efficacy and compliance.
Pharmacy Details:
Chartwell Pennsylvania, Lp type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Chartwell Pennsylvania, Lp |
| Type: | Home Infusion Therapy Pharmacy |
| Location: | 1518 9th Avenue, Altoona,
Pennsylvania, 16602-2417 |
| Phone: | 814-941-0106 |
| Fax: | 412-920-2883 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Kathleen Patrick |
| Position: | President |
| Contact Number: | 412-733-1910 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1467871418 |
| Parent Organization: | Upmc |
| NPI Enumeration Date: | 07 Apr, 2014 |
| NPI Last Update On: | 08 Nov, 2022 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Chartwell Pennsylvania, Lp are as mentioned below.
| Specialization | License Number | State | Status | |
| Home Infusion Therapy Pharmacy | | | Primary | |
| Parenteral & Enteral Nutrition | | | Secondary | |
Medicare Enrollment:
Chartwell Pennsylvania, Lp is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 4082799077 | O20141011000241 | Chartwell Pennsylvania, L.p. | DME SUPPLIER - PHARMACY |
Products Available:
Chartwell Pennsylvania, Lp has following products available for sale under medicare.
| Products: |
|---|
| • Infusion Pumps & Supplies: External Infusion | • Infusion Pumps & Supplies: Implanted Infusion |
| • Parenteral Equipment And/or Supplies | • Parenteral Nutrients |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | Po Box 360552,
Pittsburgh, Pennsylvania |
| Zip: | 15251-6552 |
| Phone Number: | 412-920-7500 |
| Fax Number: | 412-515-8961 |
Patients can reach Chartwell Pennsylvania, Lp at
1518 9th Avenue, Altoona, Pennsylvania or can
call on customer care at 814-941-0106.
Comments/ Reviews:
Read all the reviews posted for Chartwell Pennsylvania, Lp below. You may also share your own experience with Chartwell Pennsylvania, Lp. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.